United Therapeutics Corp. (NASDAQ:UTHR) is one of the 11 best debt-free stocks to invest in right now. The company boasts a ...

In a historic breakthrough for regional healthcare, Cleveland Clinic Abu Dhabi has become the first medical institution in ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts.

Cleveland Clinic Abu Dhabi has made history by performing the Gulf region’s first-ever robotic lung transplant, making it one ...

Abu Dhabi: The Gulf region’s first robotic lung transplant has been performed at Cleveland Clinic Abu Dhabi (CCAD), placing it among only five centres worldwide to have accomplished this complex ...

Cleveland Clinic Abu Dhabi has made history by performing the Gulf region’s first-ever robotic lung transplant making it one ...

Pulmonary rehabilitation is initiated and completed by a greater proportion of patients with IPF vs COPD or other chronic respiratory disorders.

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced the receipt of an additional $50.0 ...

The secrets of idiopathic pulmonary fibrosis (IPF) are written in its very name. Idiopathic refers to a disease of unknown cause, and the condition, which turns healthy lung tissue into fibrous scar ...

Introduction: This study aimed to investigate the characteristics of inflammation-fibrosis coupling in different pulmonary artery hypertension (PAH) types through 18 F-labeled fibroblast activation ...

The FDA has approved YUTREPIA™ (treprostinil) inhalation powder, developed by Liquidia Corporation, as a treatment option for adults with pulmonary arterial hypertension (PAH) and pulmonary ...